ID
41530
Description
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma
Mots-clés
Versions (2)
- 21/09/2020 21/09/2020 -
- 02/11/2020 02/11/2020 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
2 novembre 2020
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162
Chronic and concomitant medication; Concomitant vaccination (Report Final and Annex Report 2 Final)
Description
Chronic and concomitant medication
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C0013227
- UMLS CUI-3
- C0205191
Description
Have any chronic or concomitant medications/treatments (other than anti-cancer treatment) been administered?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2347852
- UMLS CUI [2,1]
- C0013227
- UMLS CUI [2,2]
- C0205191
- UMLS CUI [3]
- C0920425
Description
Chronic and concomitant medication
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C0013227
- UMLS CUI-3
- C0205191
Description
Trade/ Generic Name
Type de données
text
Alias
- UMLS CUI [1]
- C0013227
Description
Medical Indication
Type de données
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Description
Medications/ Treatments status
Type de données
integer
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0087111
- UMLS CUI [3]
- C0449438
Description
Total daily dose
Type de données
text
Alias
- UMLS CUI [1,1]
- C2348070
- UMLS CUI [1,2]
- C0439810
Description
Administration route
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Medication Start date
Type de données
date
Alias
- UMLS CUI [1]
- C2826734
Description
Medication end date
Type de données
date
Alias
- UMLS CUI [1]
- C2826744
Description
Medication continuing at end of study
Type de données
boolean
Alias
- UMLS CUI [1]
- C1553904
Description
Concomitant Vaccination
Alias
- UMLS CUI-1
- C0042196
- UMLS CUI-2
- C2347852
Description
Concomitant Vaccination
Alias
- UMLS CUI-1
- C0042196
- UMLS CUI-2
- C2347852
Description
Trade / (Generic) Name
Type de données
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C2360065
Description
Vaccine administration route
Type de données
text
Alias
- UMLS CUI [1,1]
- C0013153
- UMLS CUI [1,2]
- C0042210
Description
Vaccine administration date
Type de données
date
Alias
- UMLS CUI [1,1]
- C2368628
- UMLS CUI [1,2]
- C0011008
Similar models
Chronic and concomitant medication; Concomitant vaccination (Report Final and Annex Report 2 Final)
C0013227 (UMLS CUI-2)
C0205191 (UMLS CUI-3)
C0013227 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0920425 (UMLS CUI [3])
C0013227 (UMLS CUI-2)
C0205191 (UMLS CUI-3)
C0013227 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2])
C0449438 (UMLS CUI [3])
C0439810 (UMLS CUI [1,2])
C2347852 (UMLS CUI-2)
C2348563 (UMLS CUI [1,2])
C2347852 (UMLS CUI-2)
C2360065 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])